← Eichor
Study identifier: NCT06573437 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Performance of the VESTO® Vascular Stent for Treatment of Iliac Peripheral Obstructive Arterial Disease

Condition: Peripheral Arterial Disease  ·  Sponsor: Braile Biomedica Ind. Com. e Repr. Ltda.

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will validate the efficacy and safety of the VESTO® Vascular Stent for treating patients with iliac peripheral arterial obstructive disease in a post-market clinical trial

This description comes directly from the study's public registry record.

Talk to the study team

Glaucia Basso  ·  +55 (17) 2136-7005  ·  glaucia.basso@braile.com.br

Always discuss trial participation with your own doctor first.

Locations (6)

Hospital Ana NerySalvador, Estado de Bahia, BrazilRecruiting
Hospital Santa HelenaGoiânia, Goiás, BrazilRecruiting
Hospital Universitário Pedro Ernesto (HUPE-UERJ)Rio de Janeiro, Rio de Janeiro, BrazilRecruiting
HCFMB-UNESP - Hospital das Clínicas da Faculdade de Medicina de Botucatu da Universidade Estadual PaulistaBotucatu, São Paulo, BrazilRecruiting
Hospital de Clínicas da Universidade Estadual de CampinasCampinas, São Paulo, BrazilNot Yet Recruiting
Hospital das Clínicas da Faculdade de Medicina de Ribeirão PretoRibeirão Preto, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06573437